Degradat
CancerDip
home
Introduction
Objectives
News
Consortium
Links
Publications
Contact
Workshop
Esteller
Fuks
Stunnenberg
Altucci
Lengauer&Bock
Magdalena

DNA Methylation: from Biology to Disease

Cancerdip is a European research initiative funded by the 7th Framework Programme for Research and Technological Development of the European Commission (FP7).

Zapalenie pochwy
choroby-weneryczne.pl/bakteryjne-zapalenie-pochwy.html
Niepokojące swędzenie miejsc intymnych? Zapalenie pochwy nie musi Cię męczyć – zwalcz je dziś!
Opryszczka
choroby-weneryczne.pl/opryszczka-narzadow-plciowych.html
Opryszczka nie tylko na ustach? Zlikwiduj wstydliwą dolegliwość skutecznie!
 

The international team of experts involved in CANCERDIP consortium represent complementing scientific disciplines that joint forces to decipher the language of the epigenetic control that lead to human cancer. It is well established that tumor suppressor genes undergo epigenetic inactivation in cancer in a tumour-type specific fashion, however epigenomic approaches to cover the entire range of genes affected by epigenetic inactivation need to be used. The identification of the methylation patterns in different tumour types, as well as the identification of the epigenetic machinery involved in the establishment of these aberrant patterns, is key not only to understand the pathway that leads to cancer but also to generate markers with invaluable clinical value. A great deal of the technology used in this project is based in the MeDIP (Methyl-DNA Immuno-Precipitation). Scientists with outstanding reputation in their respective fields have been gathered to improve the knowledge on epigenetics and its involvement in human cancer. Furthermore, they are going to design, built and validate a MeDIP technology based platform to understand the epigenetic events that occur in human cancer and to help in the clinical management of human neoplasia. The team is form by a multidisciplinary and highly-competitive community of European scientists very well suited to this task as they bring together a set of skills that complements the objectives in this research area.

Sildenafil
Sildenafil

Nie pozwól aby problemy z potencją Cie zatrzymywały - ciesz się życiem już dziś!
http://eimpotencja.pl/sildenafil.html
aldara
Aldara

Swędzenie i upławy nie muszą Ci więcej towarzyszyć – przekonaj się sama!
choroby-weneryczne.pl/aldara.html
Full project Title:   The Use of Methylated DNA Immunoprecipitation (MeDIP) in Cancer for better Clinical Management
Project Type:   Collaborative Project, Small or medium-scale focused research project
Project Reference:  HEALTH-F2-2007-200620  
Number of partners: 6
Coordinator:      Dr Manel Esteller, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona
Start Date: 01.01.2008
End Date: 30.06.2011
   
   

     

 

 

                  

                   

 

 

Introduction
| CANCERDIP is funded under the European Commission's 7th Framework Programme for Research and Technological Development |
line
The Use of MeDIP in Cancer for Better Clinical Management
line